Crossmark

Targeting the tumor stroma with an oncolytic adenovirus secreting a fibroblast activation protein-targeted bispecific T-cell engager

Crossref DOI link: https://doi.org/10.1186/s40425-019-0505-4

Published Online: 2019-01-25

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

de Sostoa, Jana

Fajardo, Carlos Alberto

Moreno, Rafael

Ramos, Maria D.

Farrera-Sal, Martí

Alemany, Ramon http://orcid.org/0000-0001-8660-550X
Funding

Funding for this research was provided by:

Ministerio de Economía y Competividad (BIO2014-57716-C2-1-R, BIO2017-897554-C2-1-R, BIO2015-68990-REDT)

Generalitat de Catalunya (COMRDI15-1-0013, 2014SGR364)
More Information

Article History

Received: 6 September 2018

Accepted: 10 January 2019

First Online: 25 January 2019

Ethics approval and consent to participate

: All in vivo experiments were reviewed and approved by the Ethics Committee for Animal Experimentation from Biomedical Research Institute of Bellvitge (IDIBELL).

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.